MOMELOTINIB

MOMELOTINIB was reported 1481 times

MOMELOTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ASXL1 GENE MUTATION 2 0.2222
1 MYELOBLAST COUNT DECREASED 2 0.2000
2 ORBITAL HAEMORRHAGE 1 0.0323
3 MYELOFIBROSIS 96 0.0317
4 SPLEEN PALPABLE 2 0.0260
5 HYPOSPLENISM 1 0.0256
6 VENIPUNCTURE 1 0.0233
7 ABNORMAL ORGAN GROWTH 1 0.0227
8 SELECTIVE IGG SUBCLASS DEFICIENCY 2 0.0213
9 VASCULAR DEVICE USER 1 0.0196
10 LINEAGE SWITCH LEUKAEMIA 1 0.0189
11 PAGE KIDNEY 1 0.0167
12 MALIGNANT GENITOURINARY TRACT NEOPLASM 1 0.0149
13 MYELOBLAST COUNT INCREASED 1 0.0130
14 PRIMARY MYELOFIBROSIS 4 0.0124
15 COUGH VARIANT ASTHMA 1 0.0119
16 VEXAS SYNDROME 1 0.0104
17 TOOTH RESTORATION 1 0.0094
18 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 6 0.0091
19 HYPOTENSIVE CRISIS 1 0.0069
20 INTESTINAL HAEMATOMA 1 0.0057
21 ESSENTIAL THROMBOCYTHAEMIA 2 0.0054
22 ASPIRATION JOINT 1 0.0050
23 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1 0.0047
24 SKIN PRESSURE MARK 1 0.0047
25 RETICULOCYTOSIS 1 0.0047
26 IMMOBILISATION SYNDROME 1 0.0047
27 LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED 1 0.0046
28 ALANINE AMINOTRANSFERASE 1 0.0045
29 SPLENOMEGALY 53 0.0045
30 KL-6 INCREASED 1 0.0044
31 PLEURAL INFECTION 1 0.0043
32 SEVERE CUTANEOUS ADVERSE REACTION 1 0.0042
33 BLAST CELLS PRESENT 2 0.0042
34 SUDDEN VISUAL LOSS 1 0.0036
35 TRANSFUSION REACTION 3 0.0034
36 ERYTHROPOIESIS ABNORMAL 1 0.0033
37 INCARCERATED HERNIA 1 0.0032
38 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
39 LOSS OF PROPRIOCEPTION 1 0.0031
40 ACUTE LEUKAEMIA 5 0.0031
41 CYTOKINE STORM 2 0.0029
42 HERPES ZOSTER MENINGOENCEPHALITIS 1 0.0028
43 HERPES SIMPLEX REACTIVATION 1 0.0026
44 PANCREAS INFECTION 1 0.0025
45 VIRAL RASH 1 0.0025
46 POLYCYTHAEMIA VERA 2 0.0024
47 RED BLOOD CELL TRANSFUSION 1 0.0024
48 TRANSPLANTATION COMPLICATION 1 0.0024
49 POLYCHONDRITIS 1 0.0024
50 PHLEBITIS SUPERFICIAL 1 0.0024
51 HEARING AID USER 1 0.0023
52 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
53 MINERAL SUPPLEMENTATION 1 0.0022
54 MALIGNANT TRANSFORMATION 1 0.0022
55 BIOPSY BONE MARROW ABNORMAL 1 0.0022
56 IMMUNOGLOBULINS INCREASED 1 0.0021
57 PERIPHERAL ARTERY THROMBOSIS 3 0.0021
58 PLATELET COUNT INCREASED 26 0.0020
59 CAROTID ARTERIOSCLEROSIS 2 0.0019
60 CYTOGENETIC ANALYSIS ABNORMAL 2 0.0019
61 THROMBOCYTOSIS 7 0.0019
62 BLAST CELL COUNT INCREASED 2 0.0019
63 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 1 0.0019
64 GRIEF REACTION 1 0.0019
65 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
66 BLEEDING VARICOSE VEIN 1 0.0018
67 CLAUSTROPHOBIA 2 0.0018
68 LEUKAEMIA 17 0.0018
69 SPLEEN DISORDER 3 0.0018
70 THOUGHT BLOCKING 1 0.0017
71 URETHRAL PAIN 1 0.0017
72 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
73 PLATELET COUNT ABNORMAL 10 0.0017
74 PNEUMONIA NECROTISING 1 0.0015
75 CHONDROCALCINOSIS 1 0.0015
76 MYELOPROLIFERATIVE NEOPLASM 1 0.0015
77 WHITE BLOOD CELL DISORDER 4 0.0015
78 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
79 ABSCESS NECK 1 0.0015
80 ACUTE MYELOID LEUKAEMIA 23 0.0015
81 RED BLOOD CELL COUNT INCREASED 4 0.0014
82 INTENSIVE CARE 2 0.0014
83 HAEMOGLOBIN ABNORMAL 9 0.0014
84 PROTEUS INFECTION 1 0.0014
85 DYSLALIA 1 0.0014
86 EMERGENCY CARE 4 0.0013
87 MARASMUS 2 0.0013
88 ARTERIAL RUPTURE 1 0.0013
89 GASTROSTOMY 2 0.0013
90 EXTRADURAL ABSCESS 1 0.0013
91 TUMOUR EXCISION 1 0.0012
92 COLONIC ABSCESS 1 0.0012
93 CRANIOFACIAL FRACTURE 1 0.0012
94 PHYSICAL DECONDITIONING 3 0.0012
95 ABSCESS DRAINAGE 1 0.0012
96 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 1 0.0011
97 CEREBELLAR ATROPHY 1 0.0011
98 HYPERLEUKOCYTOSIS 1 0.0011
99 ESSENTIAL HYPERTENSION 2 0.0011
100 CERUMEN IMPACTION 1 0.0011
101 BLOOD IRON INCREASED 2 0.0011
102 INJECTION SITE ULCER 1 0.0011
103 CEREBELLAR ATAXIA 1 0.0010
104 PYELOCALIECTASIS 1 0.0010
105 BLADDER CATHETERISATION 1 0.0010
106 PYELONEPHRITIS ACUTE 2 0.0010
107 THROMBOCYTOPENIA 112 0.0010
108 DROWNING 1 0.0010
109 STRESS URINARY INCONTINENCE 1 0.0009
110 PORTAL VEIN THROMBOSIS 3 0.0009
111 IRON OVERLOAD 1 0.0009
112 LISTERIOSIS 1 0.0009
113 HAEMOGLOBIN INCREASED 4 0.0009
114 BLOOD URIC ACID INCREASED 5 0.0009
115 AORTIC THROMBOSIS 1 0.0009
116 TRANSFUSION 9 0.0009
117 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
118 FEBRILE INFECTION 1 0.0008
119 ACUTE LUNG INJURY 1 0.0008
120 HAEMATOLOGICAL INFECTION 2 0.0008
121 EYE OEDEMA 2 0.0008
122 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
123 HEPATIC ENZYME ABNORMAL 4 0.0008
124 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
125 HEPATIC INFECTION 1 0.0008
126 BLOOD BILIRUBIN ABNORMAL 1 0.0008
127 INFUSION SITE IRRITATION 1 0.0008
128 PLATELET TRANSFUSION 1 0.0008
129 SINUS ARRHYTHMIA 1 0.0008
130 EXTRADURAL HAEMATOMA 1 0.0008
131 OESOPHAGEAL HAEMORRHAGE 1 0.0008
132 ACROCHORDON 1 0.0008
133 IMMUNOGLOBULINS DECREASED 1 0.0007
134 LEUKOCYTOSIS 13 0.0007
135 NEUTROPHIL COUNT ABNORMAL 2 0.0007
136 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
137 PNEUMATOSIS INTESTINALIS 2 0.0007
138 NOROVIRUS INFECTION 1 0.0007
139 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
140 VARICES OESOPHAGEAL 2 0.0007
141 INFECTIOUS PLEURAL EFFUSION 1 0.0007
142 CHRONIC MYELOID LEUKAEMIA 3 0.0006
143 HAEMOGLOBIN DECREASED 66 0.0006
144 FUNGAEMIA 1 0.0006
145 NEUROPATHY PERIPHERAL 59 0.0006
146 SPLENIC RUPTURE 1 0.0006
147 SALMONELLOSIS 1 0.0006
148 SKIN WOUND 1 0.0006
149 ENTERITIS INFECTIOUS 1 0.0006
150 PLATELET COUNT DECREASED 62 0.0006
151 SPLENIC INFARCTION 1 0.0006
152 PSEUDOMONAL SEPSIS 1 0.0006
153 EMBOLIC STROKE 2 0.0006
154 COMPRESSION FRACTURE 3 0.0006
155 AURA 1 0.0005
156 BONE DENSITY ABNORMAL 2 0.0005
157 TUNNEL VISION 1 0.0005
158 PRODUCT STORAGE ISSUE 2 0.0005
159 BONE MARROW TRANSPLANT 1 0.0005
160 RED BLOOD CELL COUNT DECREASED 15 0.0005
161 RHEUMATIC DISORDER 1 0.0005
162 TRAUMATIC LUNG INJURY 1 0.0005
163 HYPERAEMIA 1 0.0005
164 ORGAN FAILURE 2 0.0005
165 BLOOD POTASSIUM INCREASED 8 0.0005
166 SUBARACHNOID HAEMORRHAGE 5 0.0005
167 BREAST DISORDER 1 0.0005
168 CYTOPENIA 6 0.0005
169 SUBILEUS 1 0.0005
170 URINARY BLADDER HAEMORRHAGE 1 0.0005
171 ANAEMIA MACROCYTIC 1 0.0005
172 NIGHT SWEATS 15 0.0005
173 EXOPHTHALMOS 1 0.0005
174 JAW FRACTURE 1 0.0005
175 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
176 CEREBELLAR SYNDROME 1 0.0005
177 RENAL IMPAIRMENT 38 0.0005
178 ANAEMIA 86 0.0005
179 GASTROINTESTINAL ULCER 1 0.0005
180 FAECES PALE 1 0.0004
181 FULL BLOOD COUNT DECREASED 9 0.0004
182 BRAIN FOG 7 0.0004
183 RENAL COLIC 1 0.0004
184 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
185 NEPHROGENIC ANAEMIA 2 0.0004
186 HYPERTRANSAMINASAEMIA 3 0.0004
187 RENAL FUNCTION TEST ABNORMAL 2 0.0004
188 PERFORMANCE STATUS DECREASED 2 0.0004
189 TRANSPLANT 1 0.0004
190 SUBDURAL HAEMATOMA 6 0.0004
191 RADIUS FRACTURE 1 0.0004
192 HOSPITALISATION 63 0.0004
193 INFREQUENT BOWEL MOVEMENTS 1 0.0004
194 STEM CELL TRANSPLANT 1 0.0004
195 PLATELET DISORDER 1 0.0004
196 URINARY TRACT INFECTION BACTERIAL 1 0.0004
197 HEPATOSPLENOMEGALY 1 0.0004
198 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
199 BLOOD CREATININE INCREASED 25 0.0004
200 LUNG OPACITY 1 0.0004
201 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
202 BLOOD PHOSPHORUS INCREASED 1 0.0004
203 NONSPECIFIC REACTION 2 0.0004
204 THERAPEUTIC RESPONSE DELAYED 1 0.0004
205 ELECTRIC SHOCK SENSATION 1 0.0004
206 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
207 ADVERSE DRUG REACTION 32 0.0004
208 CEREBRAL THROMBOSIS 1 0.0004
209 CHOLECYSTITIS ACUTE 2 0.0004
210 HAEMATOLOGICAL MALIGNANCY 1 0.0004
211 GASTROENTERITIS 5 0.0003
212 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
213 PLEURISY 2 0.0003
214 CEREBRAL HAEMORRHAGE 12 0.0003
215 SYMPTOM RECURRENCE 2 0.0003
216 THYROIDITIS 1 0.0003
217 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
218 BONE MARROW DISORDER 1 0.0003
219 CRANIOCEREBRAL INJURY 1 0.0003
220 UROSEPSIS 3 0.0003
221 PORTAL HYPERTENSION 1 0.0003
222 GENERALISED OEDEMA 4 0.0003
223 ERYTHEMA MULTIFORME 3 0.0003
224 SQUAMOUS CELL CARCINOMA 3 0.0003
225 DERMATITIS ALLERGIC 4 0.0003
226 IRIDOCYCLITIS 1 0.0003
227 HEPATITIS B REACTIVATION 1 0.0003
228 POLYMYALGIA RHEUMATICA 1 0.0003
229 ORTHOPNOEA 1 0.0003
230 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
231 CARDIAC FAILURE 25 0.0003
232 LIVER ABSCESS 1 0.0003
233 LYMPHOCYTE COUNT INCREASED 1 0.0003
234 HOSPICE CARE 3 0.0003
235 CORONAVIRUS INFECTION 2 0.0003
236 RENAL DISORDER 14 0.0003
237 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
238 NEPHRITIS 1 0.0003
239 LEFT VENTRICULAR FAILURE 1 0.0003
240 BLOOD CREATININE ABNORMAL 1 0.0003
241 BLOOD TEST ABNORMAL 4 0.0003
242 SKIN LACERATION 3 0.0003
243 MONOCYTE COUNT INCREASED 1 0.0003
244 OESOPHAGITIS 3 0.0003
245 AMYLASE INCREASED 1 0.0003
246 CEREBRAL DISORDER 2 0.0003
247 HEPATOTOXICITY 6 0.0003
248 FACE INJURY 1 0.0003
249 INTERNAL HAEMORRHAGE 3 0.0003
250 HYPERTHERMIA 2 0.0003
251 POLYNEUROPATHY 3 0.0003
252 NEUTROPENIA 34 0.0002
253 SKIN PAPILLOMA 1 0.0002
254 INTRACRANIAL ANEURYSM 1 0.0002
255 PERIPHERAL ISCHAEMIA 1 0.0002
256 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
257 DEMYELINATION 1 0.0002
258 ARTHRITIS BACTERIAL 1 0.0002
259 HYPERURICAEMIA 1 0.0002
260 AORTIC DISSECTION 1 0.0002
261 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
262 PNEUMONIA ASPIRATION 6 0.0002
263 TENSION HEADACHE 1 0.0002
264 SKIN CANCER 5 0.0002
265 MUSCLE STRAIN 2 0.0002
266 PNEUMONIA 74 0.0002
267 ABDOMINAL ABSCESS 1 0.0002
268 BLOOD CREATINE INCREASED 1 0.0002
269 URINARY TRACT INFECTION 38 0.0002
270 IRON DEFICIENCY 1 0.0002
271 DISEASE COMPLICATION 1 0.0002
272 ARTHRITIS INFECTIVE 1 0.0002
273 DIALYSIS 3 0.0002
274 BLOOD URINE PRESENT 4 0.0002
275 HERPES ZOSTER 12 0.0002
276 NON-SMALL CELL LUNG CANCER 1 0.0002
277 DIZZINESS POSTURAL 2 0.0002
278 INCORRECT DOSAGE ADMINISTERED 1 0.0002
279 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
280 THERAPY CHANGE 2 0.0002
281 STAPHYLOCOCCAL SEPSIS 1 0.0002
282 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
283 HYPERVOLAEMIA 1 0.0002
284 VEIN DISORDER 1 0.0002
285 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
286 CORONARY ARTERY STENOSIS 1 0.0002
287 DYSPHORIA 1 0.0002
288 TASTE DISORDER 4 0.0002
289 NEUTROPHIL COUNT DECREASED 8 0.0002
290 AMMONIA INCREASED 1 0.0002
291 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
292 FEMORAL NECK FRACTURE 1 0.0002
293 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
294 CEREBRAL ISCHAEMIA 1 0.0002
295 LYMPHOMA 3 0.0002
296 PERIORBITAL OEDEMA 1 0.0002
297 RESPIRATORY TRACT INFECTION 5 0.0002
298 PETECHIAE 2 0.0002
299 HEPATIC FUNCTION ABNORMAL 7 0.0002
300 BREAST PAIN 2 0.0002
301 CONDITION AGGRAVATED 57 0.0002
302 INTERSTITIAL LUNG DISEASE 9 0.0002
303 DECREASED ACTIVITY 2 0.0002
304 INTESTINAL ISCHAEMIA 1 0.0002
305 HYPERKERATOSIS 1 0.0002
306 HYPERTENSIVE CRISIS 2 0.0002
307 DISEASE PROGRESSION 21 0.0002
308 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
309 PRODUCT AVAILABILITY ISSUE 4 0.0002
310 CHOLECYSTECTOMY 2 0.0002
311 GASTRIC HAEMORRHAGE 2 0.0002
312 EXERCISE TOLERANCE DECREASED 1 0.0002
313 INFECTION 25 0.0002
314 RALES 1 0.0002
315 STRESS CARDIOMYOPATHY 1 0.0002
316 SKIN WARM 1 0.0002
317 ASCITES 5 0.0002
318 LABORATORY TEST ABNORMAL 5 0.0002
319 BLOOD IRON DECREASED 2 0.0002
320 THERAPY INTERRUPTED 12 0.0002
321 GOUT 3 0.0002
322 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
323 RESTLESS LEGS SYNDROME 3 0.0002
324 THERAPEUTIC RESPONSE DECREASED 10 0.0002
325 NEURALGIA 4 0.0002
326 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
327 TOOTH EXTRACTION 2 0.0002
328 SWELLING OF EYELID 1 0.0002
329 INFUSION SITE SWELLING 1 0.0002
330 THERAPY CESSATION 8 0.0002
331 INFUSION SITE PAIN 2 0.0002
332 EAR PAIN 3 0.0002
333 HEPATITIS ACUTE 1 0.0002
334 BONE PAIN 9 0.0002
335 BEDRIDDEN 2 0.0002
336 WALKING AID USER 1 0.0002
337 PRODUCT FORMULATION ISSUE 1 0.0002
338 SINUS DISORDER 3 0.0002
339 ACUTE KIDNEY INJURY 23 0.0002
340 CARDIAC FAILURE ACUTE 1 0.0001
341 MENINGITIS 1 0.0001
342 CYTOKINE RELEASE SYNDROME 3 0.0001
343 TERMINAL STATE 1 0.0001
344 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
345 BRONCHIECTASIS 1 0.0001
346 ILL-DEFINED DISORDER 9 0.0001
347 EPISTAXIS 11 0.0001
348 INFARCTION 1 0.0001
349 EYE MOVEMENT DISORDER 1 0.0001
350 LYMPHOEDEMA 1 0.0001
351 PULMONARY HYPERTENSION 3 0.0001
352 AUTOIMMUNE HEPATITIS 1 0.0001
353 FORMICATION 1 0.0001
354 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
355 ASTHENIA 53 0.0001
356 THERMAL BURN 1 0.0001
357 INTENTIONAL DOSE OMISSION 4 0.0001
358 LIVER FUNCTION TEST INCREASED 3 0.0001
359 HYPOTENSION 28 0.0001
360 HYPERSOMNIA 4 0.0001
361 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
362 VISUAL FIELD DEFECT 1 0.0001
363 MYELODYSPLASTIC SYNDROME 2 0.0001
364 FAECES SOFT 1 0.0001
365 MOUTH HAEMORRHAGE 1 0.0001
366 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
367 STEVENS-JOHNSON SYNDROME 3 0.0001
368 SEPSIS 15 0.0001
369 COLON CANCER 2 0.0001
370 HAEMORRHAGE INTRACRANIAL 2 0.0001
371 GENERAL SYMPTOM 1 0.0001
372 BREAST TENDERNESS 1 0.0001
373 PAROSMIA 1 0.0001
374 TROPONIN INCREASED 1 0.0001
375 DEATH 113 0.0001
376 EMOTIONAL DISORDER 4 0.0001
377 ATRIOVENTRICULAR BLOCK 1 0.0001
378 CONCUSSION 1 0.0001
379 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
380 EJECTION FRACTION DECREASED 2 0.0001
381 RENAL FAILURE 17 0.0001
382 PULMONARY HAEMORRHAGE 1 0.0001
383 BALANCE DISORDER 11 0.0001
384 DIZZINESS 63 0.0001
385 ATRIAL FLUTTER 1 0.0001
386 PANCYTOPENIA 7 0.0001
387 BLOOD PRESSURE FLUCTUATION 3 0.0001
388 BLOOD DISORDER 1 0.0001
389 MIOSIS 1 0.0001
390 PYREXIA 43 0.0001
391 CEREBRAL INFARCTION 3 0.0001
392 ESCHERICHIA INFECTION 1 0.0001
393 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
394 DIARRHOEA 78 0.0001
395 ACUTE CORONARY SYNDROME 1 0.0001
396 SECOND PRIMARY MALIGNANCY 1 0.0001
397 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
398 SENSATION OF FOREIGN BODY 1 0.0001
399 INFUSION SITE ERYTHEMA 1 0.0001
400 HAEMATEMESIS 3 0.0001
401 PSEUDOMONAS INFECTION 1 0.0001
402 ILLNESS 12 0.0001
403 SKIN ULCER 3 0.0001
404 DYSPHAGIA 11 0.0001
405 BLOOD MAGNESIUM DECREASED 1 0.0001
406 DELIRIUM 4 0.0001
407 SEPTIC SHOCK 5 0.0001
408 CONTUSION 11 0.0001
409 HYPERKALAEMIA 4 0.0001
410 DRUG INTOLERANCE 11 0.0001
411 GROIN PAIN 1 0.0001
412 PURPURA 1 0.0001
413 DRUG ERUPTION 2 0.0001
414 MYOSITIS 1 0.0001
415 ANAL INCONTINENCE 1 0.0001
416 MENTAL STATUS CHANGES 3 0.0001
417 DECREASED APPETITE 25 0.0001
418 INFLUENZA 12 0.0001
419 DEMENTIA 3 0.0001
420 BACTERIAL INFECTION 2 0.0001
421 HEPATIC ENCEPHALOPATHY 1 0.0001
422 NEPHROPATHY 1 0.0001
423 HEPATIC CIRRHOSIS 2 0.0001
424 BLOOD SODIUM DECREASED 2 0.0001
425 HAEMATOTOXICITY 1 0.0001
426 PRESCRIBED OVERDOSE 2 0.0001
427 LIVER FUNCTION TEST ABNORMAL 3 0.0001
428 CHOKING 2 0.0001
429 ORAL HERPES 2 0.0001
430 PHARYNGEAL SWELLING 1 0.0001
431 COELIAC DISEASE 1 0.0001
432 VITREOUS FLOATERS 1 0.0001
433 BRAIN INJURY 1 0.0001
434 PERITONITIS BACTERIAL 1 0.0001
435 STOMATITIS 6 0.0001
436 DRY THROAT 1 0.0001
437 SLUGGISHNESS 1 0.0001
438 NEUTROPHIL COUNT INCREASED 1 0.0001
439 EAR DISCOMFORT 1 0.0001
440 HYPERBILIRUBINAEMIA 1 0.0001
441 EYE DISCHARGE 1 0.0001
442 PRODUCT USE ISSUE 18 0.0001
443 WITHDRAWAL SYNDROME 4 0.0001
444 HEAD INJURY 3 0.0001
445 INCONTINENCE 1 0.0001
446 SUDDEN DEATH 1 0.0001
447 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
448 FALL 31 0.0001
449 FATIGUE 72 0.0001
450 ATRIAL FIBRILLATION 9 0.0001
451 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
452 MELAENA 2 0.0001
453 HAEMATOCHEZIA 5 0.0001
454 DENTAL CARIES 1 0.0001
455 BLOOD PRESSURE DECREASED 6 0.0001
456 GAIT INABILITY 3 0.0001
457 ABDOMINAL DISCOMFORT 15 0.0001
458 NEPHROPATHY TOXIC 1 0.0001
459 INTESTINAL PERFORATION 1 0.0001
460 FLATULENCE 5 0.0001
461 HEPATIC ENZYME INCREASED 6 0.0001
462 SCAB 1 0.0001
463 SKIN DISCOLOURATION 4 0.0001
464 NEOPLASM 1 0.0001
465 SHOCK 2 0.0001
466 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
467 LETHARGY 5 0.0001
468 MADAROSIS 1 0.0001
469 RASH MACULAR 3 0.0001
470 SURGERY 5 0.0001
471 HYPOXIA 3 0.0001
472 HYPERTENSION 18 0.0001
473 ATAXIA 1 0.0001
474 PRODUCT PRESCRIBING ERROR 2 0.0001
475 CHOLECYSTITIS 1 0.0001
476 BLOOD GLUCOSE DECREASED 4 0.0001
477 MYELOSUPPRESSION 3 0.0001
478 DEHYDRATION 11 0.0001
479 LIVER INJURY 2 0.0001
480 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
481 DYSPEPSIA 8 0.0001
482 CARDIOMEGALY 1 0.0001
483 HEART RATE INCREASED 8 0.0001
484 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
485 ILEUS 1 0.0001
486 SECRETION DISCHARGE 1 0.0001
487 DYSPNOEA EXERTIONAL 3 0.0001
488 CELLULITIS 4 0.0001
489 COLITIS 3 0.0001
490 CHRONIC KIDNEY DISEASE 6 0.0001
491 MUSCLE ATROPHY 1 0.0001
492 HYPOPHAGIA 2 0.0001
493 PRODUCT DOSE OMISSION ISSUE 23 0.0001
494 GASTROINTESTINAL DISORDER 7 0.0001
495 ROTATOR CUFF SYNDROME 1 0.0001
496 HAEMATOMA 2 0.0001
497 CHILLS 9 0.0001
498 HAEMORRHAGE 8 0.0001
499 DEAFNESS 2 0.0001
500 ORAL CANDIDIASIS 1 0.0001
501 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
502 FEELING ABNORMAL 18 0.0001
503 NEOPLASM MALIGNANT 5 0.0001
504 QUALITY OF LIFE DECREASED 1 0.0001
505 PALLOR 2 0.0001
506 ABDOMINAL PAIN 17 0.0001
507 MALAISE 32 0.0001
508 SKIN LESION 2 0.0001
509 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
510 VISION BLURRED 10 0.0001
511 PERIPHERAL COLDNESS 1 0.0001
512 RESPIRATORY DISTRESS 2 0.0001
513 NAUSEA 57 0.0001
514 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
515 HAEMOPTYSIS 2 0.0001
516 OXYGEN SATURATION DECREASED 4 0.0001
517 SEASONAL ALLERGY 1 0.0001
518 SINUS TACHYCARDIA 1 0.0001
519 PARALYSIS 1 0.0001
520 ANGINA PECTORIS 2 0.0001
521 PARAESTHESIA ORAL 1 0.0001
522 RESPIRATORY FAILURE 5 0.0001
523 PRODUCT STORAGE ERROR 6 0.0001
524 DRUG INEFFECTIVE 90 0.0001
525 ACUTE MYOCARDIAL INFARCTION 2 0.0001
526 CARDIOMYOPATHY 1 0.0001
527 IMMUNODEFICIENCY 1 0.0001
528 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
529 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
530 ANKLE FRACTURE 1 0.0001
531 ARTHRITIS 5 0.0001
532 PARAESTHESIA 10 0.0001
533 PRODUCT USE COMPLAINT 1 0.0001
534 RESPIRATORY TRACT CONGESTION 1 0.0001
535 CYSTITIS 2 0.0001
536 SCIATICA 1 0.0001
537 HYPOTHYROIDISM 2 0.0001
538 LOSS OF CONSCIOUSNESS 8 0.0001
539 THROMBOSIS 5 0.0001
540 MULTIPLE FRACTURES 1 0.0001
541 MANIA 1 0.0001
542 INFLUENZA LIKE ILLNESS 5 0.0001
543 VENTRICULAR TACHYCARDIA 1 0.0001
544 HYPOAESTHESIA 9 0.0001
545 VIRAL INFECTION 2 0.0001
546 FUNGAL INFECTION 2 0.0001
547 RASH 26 0.0001
548 CIRCULATORY COLLAPSE 1 0.0001
549 MUSCULOSKELETAL DISCOMFORT 1 0.0001
550 NEOPLASM PROGRESSION 2 0.0001
551 ABDOMINAL DISTENSION 6 0.0001
552 GAIT DISTURBANCE 11 0.0001
553 SPEECH DISORDER 3 0.0001
554 DEPRESSED MOOD 3 0.0001
555 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
556 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
557 HEAD DISCOMFORT 1 0.0001
558 ISCHAEMIC STROKE 1 0.0001
559 THIRST 1 0.0001
560 DISTURBANCE IN ATTENTION 3 0.0001
561 GASTROENTERITIS VIRAL 1 0.0001
562 OEDEMA 3 0.0001
563 ANAPHYLACTIC REACTION 3 0.0001
564 EYE SWELLING 2 0.0001
565 WEIGHT DECREASED 15 0.0001
566 CARDIAC DISORDER 5 0.0001
567 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
568 PHOTOPHOBIA 1 0.0001
569 INTESTINAL OBSTRUCTION 2 0.0001
570 DYSPNOEA 30 0.0001
571 GASTRIC ULCER 1 0.0001
572 PROTEINURIA 1 0.0001
573 CHOLESTASIS 1 0.0001
574 POST PROCEDURAL COMPLICATION 1 0.0001
575 PRURITUS 20 0.0001
576 ACUTE RESPIRATORY FAILURE 1 0.0001
577 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
578 HEADACHE 32 0.0001
579 KIDNEY INFECTION 1 0.0001
580 DISORIENTATION 2 0.0001
581 HAEMATOCRIT DECREASED 1 0.0001
582 DRUG INTERACTION 8 0.0001
583 BLOOD PRESSURE ABNORMAL 1 0.0001
584 PRESCRIBED UNDERDOSE 1 0.0001
585 SPINAL FRACTURE 1 0.0000
586 CARDIAC FAILURE CONGESTIVE 4 0.0000
587 FEEDING DISORDER 1 0.0000
588 PLEURAL EFFUSION 3 0.0000
589 OEDEMA PERIPHERAL 6 0.0000
590 BONE MARROW FAILURE 1 0.0000
591 FLUSHING 5 0.0000
592 BODY TEMPERATURE INCREASED 1 0.0000
593 RIB FRACTURE 1 0.0000
594 ABDOMINAL PAIN UPPER 10 0.0000
595 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
596 PERITONITIS 1 0.0000
597 EATING DISORDER 1 0.0000
598 RECTAL HAEMORRHAGE 2 0.0000
599 COUGH 13 0.0000
600 FAECES DISCOLOURED 1 0.0000
601 AMNESIA 3 0.0000
602 SWELLING FACE 3 0.0000
603 DEVICE DISLOCATION 2 0.0000
604 PRODUCT PRESCRIBING ISSUE 1 0.0000
605 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
606 LIVER DISORDER 2 0.0000
607 TRANSAMINASES INCREASED 1 0.0000
608 TOOTH DISORDER 1 0.0000
609 RASH MACULO-PAPULAR 1 0.0000
610 RASH PAPULAR 1 0.0000
611 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
612 OFF LABEL USE 39 0.0000
613 THERAPY NON-RESPONDER 2 0.0000
614 TINNITUS 2 0.0000
615 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
616 PERICARDIAL EFFUSION 1 0.0000
617 BLOOD CHOLESTEROL INCREASED 2 0.0000
618 COGNITIVE DISORDER 2 0.0000
619 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
620 PRODUCTIVE COUGH 2 0.0000
621 LOCALISED INFECTION 1 0.0000
622 CEREBROVASCULAR ACCIDENT 7 0.0000
623 PRESYNCOPE 1 0.0000
624 ENCEPHALOPATHY 1 0.0000
625 AGEUSIA 1 0.0000
626 SYNCOPE 4 0.0000
627 COVID-19 7 0.0000
628 ABDOMINAL PAIN LOWER 1 0.0000
629 CARDIOVASCULAR DISORDER 1 0.0000
630 CHEST DISCOMFORT 4 0.0000
631 DRUG RESISTANCE 1 0.0000
632 UNRESPONSIVE TO STIMULI 1 0.0000
633 VOMITING 18 0.0000
634 EAR INFECTION 1 0.0000
635 PAIN IN EXTREMITY 11 0.0000
636 JAUNDICE 1 0.0000
637 CONFUSIONAL STATE 6 0.0000
638 BLOOD BILIRUBIN INCREASED 1 0.0000
639 LIMB INJURY 1 0.0000
640 CONSTIPATION 8 0.0000
641 CARDIAC ARREST 3 0.0000
642 TREMOR 6 0.0000
643 DIVERTICULITIS 1 0.0000
644 FEELING COLD 1 0.0000
645 WOUND 1 0.0000
646 BLISTER 2 0.0000
647 DEPRESSION 8 0.0000
648 PANCREATIC CARCINOMA 1 0.0000
649 BACK PAIN 8 0.0000
650 MYOCARDIAL INFARCTION 6 0.0000
651 DYSSTASIA 1 0.0000
652 DRUG WITHDRAWAL SYNDROME 3 0.0000
653 PALPITATIONS 4 0.0000
654 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
655 INSOMNIA 9 0.0000
656 TACHYCARDIA 3 0.0000
657 WHEEZING 2 0.0000
658 RESPIRATORY DISORDER 1 0.0000
659 HEPATIC FAILURE 1 0.0000
660 APHASIA 1 0.0000
661 LACRIMATION INCREASED 1 0.0000
662 EPILEPSY 1 0.0000
663 PAIN 20 0.0000
664 OROPHARYNGEAL PAIN 3 0.0000
665 CHEST PAIN 6 0.0000
666 LIMB DISCOMFORT 1 0.0000
667 FEMUR FRACTURE 1 0.0000
668 SWELLING 3 0.0000
669 NERVOUS SYSTEM DISORDER 1 0.0000
670 SWOLLEN TONGUE 1 0.0000
671 METABOLIC ACIDOSIS 1 0.0000
672 HIP FRACTURE 1 0.0000
673 HYPERHIDROSIS 4 0.0000
674 RHINORRHOEA 2 0.0000
675 DEEP VEIN THROMBOSIS 2 0.0000
676 CHOLELITHIASIS 1 0.0000
677 LIP SWELLING 1 0.0000
678 SKIN DISORDER 1 0.0000
679 URINARY RETENTION 1 0.0000
680 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
681 SINUSITIS 3 0.0000
682 HAEMATURIA 1 0.0000
683 BURNING SENSATION 2 0.0000
684 SLEEP DISORDER 2 0.0000
685 LYMPHADENOPATHY 1 0.0000
686 MOBILITY DECREASED 2 0.0000
687 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
688 C-REACTIVE PROTEIN INCREASED 1 0.0000
689 HYPERGLYCAEMIA 1 0.0000
690 PANIC ATTACK 1 0.0000
691 UNDERDOSE 2 0.0000
692 ACCIDENTAL OVERDOSE 1 0.0000
693 RESTLESSNESS 1 0.0000
694 BRONCHITIS 2 0.0000
695 WEIGHT INCREASED 6 0.0000
696 DYSARTHRIA 1 0.0000
697 ARTHRALGIA 11 0.0000
698 DIABETES MELLITUS 2 0.0000
699 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
700 PROSTATE CANCER 2 0.0000
701 SOMNOLENCE 5 0.0000
702 EXTRA DOSE ADMINISTERED 1 0.0000
703 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
704 DRY MOUTH 2 0.0000
705 BLINDNESS 1 0.0000
706 OSTEOPOROSIS 1 0.0000
707 VISUAL IMPAIRMENT 3 0.0000
708 RHABDOMYOLYSIS 1 0.0000
709 POLLAKIURIA 1 0.0000
710 ROAD TRAFFIC ACCIDENT 1 0.0000
711 OSTEOARTHRITIS 1 0.0000
712 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
713 PULMONARY OEDEMA 1 0.0000
714 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
715 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
716 MEMORY IMPAIRMENT 3 0.0000
717 NASOPHARYNGITIS 4 0.0000
718 HYPOKALAEMIA 1 0.0000
719 ARRHYTHMIA 1 0.0000
720 ANXIETY 6 0.0000
721 OCULAR HYPERAEMIA 1 0.0000
722 RASH ERYTHEMATOUS 1 0.0000
723 DRY EYE 1 0.0000
724 AGGRESSION 1 0.0000
725 FLUID RETENTION 1 0.0000
726 BLOOD PRESSURE INCREASED 3 0.0000
727 PERIPHERAL SWELLING 3 0.0000
728 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
729 BRADYCARDIA 1 0.0000
730 RASH PRURITIC 1 0.0000
731 TREATMENT NONCOMPLIANCE 1 0.0000
732 NECK PAIN 1 0.0000
733 HYPONATRAEMIA 1 0.0000
734 SEIZURE 2 0.0000
735 DYSPHONIA 1 0.0000
736 BLADDER CANCER 1 0.0000
737 CATARACT 1 0.0000
738 JOINT SWELLING 2 0.0000
739 VERTIGO 1 0.0000
740 HYPERSENSITIVITY 3 0.0000
741 DEVICE DIFFICULT TO USE 1 0.0000
742 FEBRILE NEUTROPENIA 1 0.0000
743 ERYTHEMA 3 0.0000
744 SKIN BURNING SENSATION 1 0.0000
745 DYSGEUSIA 1 0.0000
746 HALLUCINATION 1 0.0000
747 HOT FLUSH 1 0.0000
748 UNEVALUABLE EVENT 1 0.0000
749 INCORRECT DOSE ADMINISTERED 3 0.0000
750 URTICARIA 2 0.0000
751 SKIN EXFOLIATION 1 0.0000
752 DEVICE ISSUE 1 0.0000
753 SUICIDAL IDEATION 1 0.0000
754 MUSCLE SPASMS 2 0.0000
755 BLOOD GLUCOSE INCREASED 2 0.0000
756 PULMONARY EMBOLISM 1 0.0000
757 MIGRAINE 1 0.0000
758 OVERDOSE 2 0.0000
759 MUSCULAR WEAKNESS 1 0.0000
760 EMOTIONAL DISTRESS 1 0.0000
761 DRY SKIN 1 0.0000
762 MYALGIA 1 0.0000
763 NO ADVERSE EVENT 1 0.0000